Savarirayan, Ravi http://orcid.org/0000-0002-5105-8427
Baratela, Wagner
Butt, Thomas
Cormier-Daire, Valérie
Irving, Melita
Miller, Bradley S.
Mohnike, Klaus
Ozono, Keiichi
Rosenfeld, Ron
Selicorni, Angelo
Thompson, Dominic http://orcid.org/0000-0002-1114-9869
White, Klane K.
Wright, Michael
Fredwall, Svein O.
Funding for this research was provided by:
BioMarin Pharmaceutical (No award number)
Article History
Received: 17 December 2021
Accepted: 29 May 2022
First Online: 13 June 2022
Declarations
:
: Not applicable.
: Not applicable.
: RS has received grants and honoraria from BioMarin and is a principal investigator in BioMarin sponsored clinical trials. WB has received honoraria from BioMarin. TB is an employee of BioMarin International Ltd. VCD has received honoraria from BioMarin. MI has received honoraria from BioMarin and is a principal investigator in BioMarin-sponsored clinical trials. BSM is a consultant for Abbvie, Ascendis Pharma, BioMarin, EMD Serono, Novo Nordisk, Orchard Therapeutics, Pfizer, Tolmar and Vertice and has received research support from Alexion, Abbvie, Amgen, Ascendis, Lumos Pharma, Novo Nordisk, OPKO Health, Pfizer, and Tolmar. KM received grants and honoraria from BioMarin, Lilly, and Novo-Nordisk and has been an advisor of QED; he is a principal investigator in BioMarin-sponsored clinical trials and member of advocacy group BKMF e.V. KO reports honoraria for lectures from BioMarin. RR has received consulting fees, payments and support for attending meetings, and participated in scientific and marketing boards from BioMarin. AS received honoraria from BioMarin for participating in the expert panel. DT has received honoraria from BioMarin. KKW has received payments, honoraria, and consulting fees from BioMarin, and grants from Ascendis, Pfizer (Theracon), and Ultragenyx, and royalties/licences from UptoDate.com. MW has received honoraria from BioMarin for acting as a Medical Advisor in the vosoritide programme. SF has received payments of consultation honoraria from BioMarin and Sanofi to his working institution. VCD, MI, KM, KO, RS, and KW are principal investigators in the vosoritide clinical trials.